anurajms/meta_analysis huggingface dataset:
Provide patient population that should be included in the study
Surgical treatment for tubal disease in women due to undergo in vitro fertilisation
1. Adult 19-44 years 2. Fallopian tube disorder 3. Subfertility 4. In Vitro Fertilization 5. Young Adult 19-24 years
Provide patient population that should be included in the study
Tubal flushing for subfertility
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Subfertility 4. Young Adult 19-24 years
Provide patient population that should be included in the study
Levonorgestrel‐releasing intrauterine system for endometrial hyperplasia
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Benign Endometrial Hyperplasia 6. Aged 65-79 years
Provide patient population that should be included in the study
Oral versus intra‐vaginal imidazole and triazole anti‐fungal treatment of uncomplicated vulvovaginal candidiasis (thrush)
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Vulvovaginal Candidiasis 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventions for non‐tubal ectopic pregnancy
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Ectopic Pregnancy 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Progestogen‐releasing intrauterine systems for heavy menstrual bleeding
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Menorrhagia
Provide patient population that should be included in the study
In‐bag manual versus uncontained power morcellation for laparoscopic myomectomy
1. Uterine fibroid 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Laparoscopic Myomectomy
Provide patient population that should be included in the study
Self‐administered versus provider‐administered medical abortion
1. Child, Preschool 2-5 years 2. Adult 19-44 years 3. Child 6-12 years 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Pregnancy 7. Abortion 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Traditional suburethral sling operations for urinary incontinence in women
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Stress urinary incontinence 6. Mixed Incontinence 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Metformin for ovulation induction (excluding gonadotrophins) in women with polycystic ovary syndrome
1. Adult 19-44 years 2. Subfertility 3. Ovulation Induction 4. Young Adult 19-24 years 5. Polycystic Ovarian Syndrome
Provide patient population that should be included in the study
Laparoscopic colposuspension for urinary incontinence in women
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Stress urinary incontinence 6. Mixed Incontinence 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Long‐term GnRH agonist therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis
1. Adult 19-44 years 2. Subfertility 3. In Vitro Fertilization 4. Young Adult 19-24 years 5. Endometriosis
Provide patient population that should be included in the study
Exercise for dysmenorrhoea
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Primary Dysmenorrhea 4. Young Adult 19-24 years 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Non‐steroidal anti‐inflammatory drugs for heavy menstrual bleeding
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Menorrhagia 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventions for treating recurrent stress urinary incontinence after failed minimally invasive synthetic midurethral tape surgery in women
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Insertion of mid-urethral sling 4. Middle Aged 45-64 years 5. Disease Recurrence 6. Young Adult 19-24 years 7. Stress urinary incontinence 8. Aged 65-79 years 9. Adolescent 13-18 years
Provide patient population that should be included in the study
Cyclical progestogens for heavy menstrual bleeding
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Menorrhagia 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Antibiotic therapy for adults with neurosyphilis
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Neurosyphilis 6. Aged 65-79 years
Provide patient population that should be included in the study
Robot‐assisted surgery in gynaecology
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Gynaeocological Condition 8. Surgery 9. Young Adult 19-24 years 10. Birth to 1 mo 11. Aged 65-79 years 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Lifestyle changes in women with polycystic ovary syndrome
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Polycystic Ovarian Syndrome 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Combined hormonal contraceptives for heavy menstrual bleeding
1. Adult 19-44 years 2. Premenopausal Menorrhagia 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventions to reduce shoulder pain following gynaecological laparoscopic procedures
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Young Adult 19-24 years 7. Laparoscopy 8. Aged 65-79 years 9. Adolescent 13-18 years
Provide patient population that should be included in the study
Endometrial resection and ablation techniques for heavy menstrual bleeding
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Menorrhagia
Provide patient population that should be included in the study
Gonadotrophins for ovulation induction in women with polycystic ovary syndrome
1. Adult 19-44 years 2. Subfertility 3. Ovulation Induction 4. Young Adult 19-24 years 5. Polycystic Ovarian Syndrome
Provide patient population that should be included in the study
Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Urinary Incontinence 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Surgery for women with pelvic organ prolapse with or without stress urinary incontinence
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Urinary Continence 4. Middle Aged 45-64 years 5. Disease Recurrence 6. Young Adult 19-24 years 7. Genital prolapse 8. Stress urinary incontinence 9. Aged 65-79 years 10. Adolescent 13-18 years
Provide patient population that should be included in the study
Acupuncture and acupressure for premenstrual syndrome
1. Premenstrual Tension Syndrome 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Premenstrual dysphoric disorder 5. Young Adult 19-24 years 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Oral contraceptives for pain associated with endometriosis
1. Adult 19-44 years 2. Young Adult 19-24 years 3. Endometriosis
Provide patient population that should be included in the study
Surgery for women with posterior compartment prolapse
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Posterior Vaginal Wall Prolapse 5. Disease Recurrence 6. Young Adult 19-24 years 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Insulin‐sensitising drugs (metformin, rosiglitazone, pioglitazone, D‐chiro‐inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
1. Adult 19-44 years 2. Oligomenorrhoea 3. Middle Aged 45-64 years 4. Subfertility 5. Young Adult 19-24 years 6. Polycystic Ovarian Syndrome
Provide patient population that should be included in the study
Preoperative medical therapy before surgery for uterine fibroids
1. Uterine fibroid 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Hysteroscopic Excision Of Leiomyoma Of Uterus 6. Hysterectomy 7. Uterine myomectomy
Provide patient population that should be included in the study
Anterior vaginal repair for urinary incontinence in women
1. Aged 80 and over 80+ years 2. Urinary urgency 3. Overactive Bladder Syndrome 4. Genital prolapse 5. Stress urinary incontinence 6. Mixed Incontinence 7. Aged 65-79 years 8. Urge Incontinence 9. Adult 19-44 years 10. Middle Aged 45-64 years 11. Urinary Frequency 12. Young Adult 19-24 years 13. Nocturia
Provide patient population that should be included in the study
Mid‐urethral sling operations for stress urinary incontinence in women
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Stress urinary incontinence 6. Mixed Incontinence 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Open retropubic colposuspension for urinary incontinence in women
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Disease Recurrence 5. Young Adult 19-24 years 6. Genital prolapse 7. Stress urinary incontinence 8. Mixed Incontinence 9. Aged 65-79 years 10. Adolescent 13-18 years
Provide patient population that should be included in the study
Bladder neck needle suspension for urinary incontinence in women
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Urodynamics measurement 5. Young Adult 19-24 years 6. Physical Examination 7. Stress urinary incontinence 8. Mixed Incontinence 9. Aged 65-79 years 10. Adolescent 13-18 years
Provide patient population that should be included in the study
Progesterone receptor modulators for endometriosis
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Endometriosis 4. Adolescent 13-18 years
Provide patient population that should be included in the study
Antibiotic prophylaxis for elective hysterectomy
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Elective hysterectomy 4. Young Adult 19-24 years
Provide patient population that should be included in the study
Selective progesterone receptor modulators (SPRMs) for uterine fibroids
1. Uterine fibroid 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Washout policies in long‐term indwelling urinary catheterisation in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Suprapubic Urinary Catheter In Situ 5. Young Adult 19-24 years 6. Perineal Urinary Catheter In Situ 7. Aged 65-79 years 8. Urethral Catheterization 9. Adolescent 13-18 years
Provide patient population that should be included in the study
Surgery for tubal infertility
1. Adult 19-44 years 2. Fallopian tube disorder 3. Subfertility 4. Young Adult 19-24 years
Provide patient population that should be included in the study
Nonsteroidal anti‐inflammatory drugs for pain in women with endometriosis
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Endometriosis 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Long‐term hormone therapy for perimenopausal and postmenopausal women
1. Adult 19-44 years 2. Osteoporosis 3. Middle Aged 45-64 years 4. Cardiovascular disease 5. Perimenopause 6. Surgical Menopause 7. Fracture 8. Postmenopausal
Provide patient population that should be included in the study
Surgery for women with anterior compartment prolapse
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Disease Recurrence 5. Cystocele 6. Anterior Vaginal Wall Prolapse 7. Young Adult 19-24 years 8. Stress urinary incontinence 9. Female Urethrocoele 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventions for preventing and treating incontinence‐associated dermatitis in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Irritant Contact Dermatitis Due To Incontinence 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Short‐term and long‐term effects of tibolone in postmenopausal women
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Perimenopause 6. Menopausal 7. Postmenopausal 8. Aged 65-79 years
Provide patient population that should be included in the study
Antibiotic treatment for the sexual partners of women with bacterial vaginosis
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Adolescent 13-18 years 7. Bacterial Vaginosis
Provide patient population that should be included in the study
Techniques for the interruption of tubal patency for female sterilisation
1. Adult 19-44 years 2. Not Pregnant 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Bioidentical hormones for women with vasomotor symptoms
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Menopausal Symptom 4. Middle Aged 45-64 years 5. Aged 65-79 years
Provide patient population that should be included in the study
Policies for replacing long‐term indwelling urinary catheters in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Suprapubic Urinary Catheter In Situ 5. Medical Device Replacement 6. Young Adult 19-24 years 7. Aged 65-79 years 8. Urethral Catheterization 9. Adolescent 13-18 years
Provide patient population that should be included in the study
Antibiotics for treating septic abortion
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Illegal Termination Of Pregnancy With Sepsis 5. Legal Termination Of Pregnancy With Sepsis 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Chinese herbal medicine for menopausal symptoms
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Menopausal Symptom 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Tricyclic and related drugs for nocturnal enuresis in children
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Adolescent 13-18 years 4. Non-organic Nocturnal Enuresis
Provide patient population that should be included in the study
Trocar types in laparoscopy
1. Aged 80 and over 80+ years 2. Laparoscopic Surgery 3. Adult 19-44 years 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Urethral (indwelling or intermittent) or suprapubic routes for short‐term catheterisation in hospitalised adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Temporary Urethral Catheterization 4. Middle Aged 45-64 years 5. Surgery 6. Young Adult 19-24 years 7. Hospitalization 8. Labor 9. Acute Retention Of Urine 10. Aged 65-79 years 11. Investigations 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Pelvic floor muscle training added to another active treatment versus the same active treatment alone for urinary incontinence in women
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Stress urinary incontinence 6. Mixed Incontinence 7. Aged 65-79 years 8. Adolescent 13-18 years 9. Urge Incontinence
Provide patient population that should be included in the study
Hormonal and intrauterine methods for contraception for women aged 25 years and younger
1. Young Adult 19-24 years 2. Adolescent 13-18 years
Provide patient population that should be included in the study
Nonsteroidal anti‐inflammatory drugs for dysmenorrhoea
1. Adult 19-44 years 2. Primary Dysmenorrhea 3. Young Adult 19-24 years 4. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventions for pain with intrauterine device insertion
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. IUD contraception 4. Intrauterine Device 5. Young Adult 19-24 years 6. Intrauterine Contraceptive Device Fitted 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Doctors or mid‐level providers for abortion
1. Induced Termination Of Pregnancy In First Trimester 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Immediate postpartum insertion of intrauterine device for contraception
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Postpartum 4. Young Adult 19-24 years 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Invasive urodynamic studies for the management of lower urinary tract symptoms (LUTS) in men with voiding dysfunction
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Adolescent 13-18 years 7. Dysfunctional Voiding Of Urine
Provide patient population that should be included in the study
Preoperative ripening of the cervix before operative hysteroscopy
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Hysteroscopy 4. Middle Aged 45-64 years 5. Cervical dilatation 6. Young Adult 19-24 years 7. Aged 65-79 years
Provide patient population that should be included in the study
Add‐back therapy with GnRH analogues for uterine fibroids
1. Uterine fibroid 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Transurethral radiofrequency collagen denaturation for the treatment of women with urinary incontinence
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Stress urinary incontinence 6. Mixed Incontinence 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Hormone therapy for preventing cardiovascular disease in post‐menopausal women
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Postmenopausal 6. Aged 65-79 years
Provide patient population that should be included in the study
Nitric oxide donors for cervical ripening in first‐trimester surgical abortion
1. Induced Termination Of Pregnancy In First Trimester 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Conservative management for postprostatectomy urinary incontinence
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Urinary Continence 4. Middle Aged 45-64 years 5. Radical Prostatectomy 6. Young Adult 19-24 years 7. Urinary Incontinence 8. Aged 65-79 years 9. Transurethral Prostatectomy 10. Adolescent 13-18 years
Provide patient population that should be included in the study
Imiquimod for anogenital warts in non‐immunocompromised adults
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Anogenital Warts 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Minimally invasive surgical techniques versus open myomectomy for uterine fibroids
1. Uterine fibroid 2. Premenopausal State 3. Middle Aged 45-64 years
Provide patient population that should be included in the study
Types of indwelling urethral catheters for short‐term catheterisation in hospitalised adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Hospitalization 6. Aged 65-79 years
Provide patient population that should be included in the study
Non‐surgical interventions for the management of chronic pelvic pain
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Chronic Pelvic Pain Of Female 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Pre‐operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding
1. Premenopausal State 2. Adult 19-44 years 3. Finding Of Menstrual Bleeding 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Aromatase inhibitors for uterine fibroids
1. Uterine fibroid 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Paracervical local anaesthesia for cervical dilatation and uterine intervention
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Cervical dilatation 4. Young Adult 19-24 years
Provide patient population that should be included in the study
Prophylactic antibiotics for transcervical intrauterine procedures
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Procedure On Uterus 6. Aged 65-79 years
Provide patient population that should be included in the study
Anti‐TNF‐α treatment for pelvic pain associated with endometriosis
1. Premenopausal State 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Endometriosis 6. Pelvic Pain 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Adapting shift work schedules for sleep quality, sleep duration, and sleepiness in shift workers
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Shift work
Provide patient population that should be included in the study
Splinting for carpal tunnel syndrome
1. Carpal Tunnel Syndrome
Provide patient population that should be included in the study
Collective leadership to improve professional practice, healthcare outcomes and staff well‐being
1. Healthcare Professional
Provide patient population that should be included in the study
Pre‐deployment programmes for building resilience in military and frontline emergency service personnel
1. Critical Incident 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Healthcare Professional 5. First Responders 6. Young Adult 19-24 years 7. Military service
Provide patient population that should be included in the study
Exercise therapy for chronic low back pain
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Chronic Low Back Pain 6. Aged 65-79 years
Provide patient population that should be included in the study
Interventions to improve return to work in depressed people
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Employee 5. Young Adult 19-24 years 6. Depression 7. Aged 65-79 years
Provide patient population that should be included in the study
Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Healthcare Professional At Risk 5. Aged 65-79 years 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Workplace interventions for increasing standing or walking for decreasing musculoskeletal symptoms in sedentary workers
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Musculoskeletal Symptom 6. Sedentary 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Work‐break schedules for preventing musculoskeletal symptoms and disorders in healthy workers
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Employee 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Healthy 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Incentives for smoking cessation
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Smoker 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Ergonomic interventions for preventing work‐related musculoskeletal disorders of the upper limb and neck among office workers
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Work Problem 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Long-sitting 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Ergonomic interventions for preventing musculoskeletal disorders in dental care practitioners
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Dentistry 5. Aged 65-79 years
Provide patient population that should be included in the study
Closed‐system drug‐transfer devices plus safe handling of hazardous drugs versus safe handling alone for reducing exposure to infusional hazardous drugs in healthcare staff
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Healthcare Professional 4. Young Adult 19-24 years 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Workplace lighting for improving alertness and mood in daytime workers
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Employee 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Multidisciplinary biopsychosocial rehabilitation for subacute low back pain
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Low back pain 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Influenza vaccination for healthcare workers who care for people aged 60 or older living in long‐term care institutions
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Healthcare Professional 4. Young Adult 19-24 years
Provide patient population that should be included in the study
Rehabilitation following carpal tunnel release
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Decompression Of Median Nerve 10. Aged 65-79 years 11. Carpal Tunnel Syndrome 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Organisational interventions for improving wellbeing and reducing work‐related stress in teachers
1. Aged 80 and over 80+ years 2. School teacher 3. Adult 19-44 years 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Exercises for mechanical neck disorders
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Disorder Of Neck 5. Nerve Root Disorder 6. Young Adult 19-24 years 7. Aged 65-79 years 8. Adolescent 13-18 years 9. Neck Pain 10. Cervicogenic Headache
Provide patient population that should be included in the study
Multidisciplinary biopsychosocial rehabilitation for chronic low back pain
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Chronic Low Back Pain 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventions for preventing the spread of infestation in close contacts of people with scabies
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Infestation By Sarcoptes Scabiei Var Ovis 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Non‐pharmacological interventions for preventing venous insufficiency in a standing worker population
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Employee 5. Young Adult 19-24 years 6. Step-standing 7. Aged 65-79 years
Provide patient population that should be included in the study
Supported employment for adults with severe mental illness
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Severe mental disorder 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Physical conditioning as part of a return to work strategy to reduce sickness absence for workers with back pain
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Work-related disability 5. Back pain
Provide patient population that should be included in the study
Therapeutic ultrasound for carpal tunnel syndrome
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Young Adult 19-24 years 7. Aged 65-79 years 8. Carpal Tunnel Syndrome 9. Adolescent 13-18 years
Provide patient population that should be included in the study
Training healthcare providers to respond to intimate partner violence against women
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Healthcare Professional 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Psychological interventions for depression and anxiety in patients with coronary heart disease, heart failure or atrial fibrillation
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Coronary Heart Disease 5. Young Adult 19-24 years 6. Heart Failure 7. Atrial Fibrillation 8. Aged 65-79 years 9. Adolescent 13-18 years
Provide patient population that should be included in the study
Mobile phone text messaging for medication adherence in secondary prevention of cardiovascular disease
1. Arterial occlusion
Provide patient population that should be included in the study
Prophylactic corticosteroids for cardiopulmonary bypass in adult cardiac surgery
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Cardiopulmonary Bypass Operation 6. Cardiac surgery 7. Coronary Artery Disease 8. Heart Valve Disorder 9. Aged 65-79 years
Provide patient population that should be included in the study
Exercise‐based cardiac rehabilitation for adults with heart failure
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Heart Failure 6. Aged 65-79 years
Provide patient population that should be included in the study
Home‐based versus centre‐based cardiac rehabilitation
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Myocardial Infarction 4. Middle Aged 45-64 years 5. Angina Pectoris 6. Young Adult 19-24 years 7. Heart Failure 8. Coronary Revascularisation 9. Aged 65-79 years 10. Adolescent 13-18 years
Provide patient population that should be included in the study
Effects of interventions targeting the systemic inflammatory response to cardiac surgery on clinical outcomes in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Cardiac surgery 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Haemostatic therapies for stroke due to acute, spontaneous intracerebral haemorrhage
1. Aged 80 and over 80+ years 2. Intracerebral Hemorrhage 3. Adult 19-44 years 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Cerebrolysin for acute ischaemic stroke
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Ischemic Stroke 6. Aged 65-79 years
Provide patient population that should be included in the study
Pravastatin for lowering lipids
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years
Provide patient population that should be included in the study
First‐line diuretics versus other classes of antihypertensive drugs for hypertension
1. Hypertensive disorder
Provide patient population that should be included in the study
Physical exercise for the treatment of non‐ulcerated chronic venous insufficiency
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Non-ulcerated Chronic Venous Insufficiency 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Risk of thromboembolism in patients with COVID‐19 who are using hormonal contraception
1. COVID-19
Provide patient population that should be included in the study
Family presence during resuscitation
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Resuscitation 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Deep Venous Thrombosis
Provide patient population that should be included in the study
Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Pulmonary Embolism 6. Aged 65-79 years
Provide patient population that should be included in the study
General versus loco‐regional anesthesia for endovascular aortic aneurysm repair
1. Aged 80 and over 80+ years 2. Thoracic endovascular repair 3. Adult 19-44 years 4. Endovascular Repair Of Abdominal Aortic Aneurysm 5. Middle Aged 45-64 years 6. Young Adult 19-24 years 7. Aged 65-79 years
Provide patient population that should be included in the study
Oral Class I and III antiarrhythmic drugs for maintaining sinus rhythm after catheter ablation of atrial fibrillation
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Catheter ablation of heart tissue 5. Young Adult 19-24 years 6. Atrial Fibrillation 7. Aged 65-79 years
Provide patient population that should be included in the study
Drugs to reduce bleeding and transfusion in major open vascular or endovascular surgery: a systematic review and network meta‐analysis
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. At Risk For Surgical Blood Loss 6. Aged 65-79 years 7. Vascular Surgery
Provide patient population that should be included in the study
Endovascular therapy versus medical treatment for symptomatic intracranial artery stenosis
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Intracranial artery stenosis 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Antithrombotic treatment after stroke due to intracerebral haemorrhage
1. Aged 80 and over 80+ years 2. Intracerebral Hemorrhage 3. Adult 19-44 years 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Intravenous immunoglobulin for the treatment of Kawasaki disease
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Kawasaki's syndrome 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Remote ischaemic preconditioning versus no remote ischaemic preconditioning for vascular and endovascular surgical procedures
1. Endovascular surgery 2. Vascular Surgery
Provide patient population that should be included in the study
Totally percutaneous versus surgical cut‐down femoral artery access for elective bifurcated abdominal endovascular aneurysm repair
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Abdominal Aortic Aneurysm 6. Aged 65-79 years
Provide patient population that should be included in the study
Peroxisome proliferator‐activated receptor gamma agonists for preventing recurrent stroke and other vascular events in people with stroke or transient ischaemic attack
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Stroke 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Transient Cerebral Ischemia
Provide patient population that should be included in the study
Balneotherapy for chronic venous insufficiency
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Venous insufficiency 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
High versus low blood pressure targets for cardiac surgery while on cardiopulmonary bypass
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Cardiac surgery 6. Cardiopulmonary Bypass 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. At Risk Of Venous Thromboembolus 6. Middle Aged 45-64 years 7. Infant 1 to 23 mo 8. Young Adult 19-24 years 9. Bariatric surgery 10. Birth to 1 mo 11. Aged 65-79 years 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Prothrombin complex concentrate in cardiac surgery for the treatment of coagulopathic bleeding
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Cardiac surgery 10. Haemorrhage 11. Aged 65-79 years 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Blood pressure targets for the treatment of people with hypertension and cardiovascular disease
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Stroke 4. Myocardial Infarction 5. Middle Aged 45-64 years 6. Angina Pectoris 7. Young Adult 19-24 years 8. Peripheral Arterial Disease 9. Aged 65-79 years 10. Hypertensive disorder 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Pharmaceutical interventions for emotionalism after stroke
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Stroke 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Showing Emotion 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Aneurysmal subarachnoid hemorrhage
Provide patient population that should be included in the study
Interventions for perceptual disorders following stroke
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Stroke 4. Middle Aged 45-64 years 5. Perceptual disorder 6. Young Adult 19-24 years 7. Aged 65-79 years
Provide patient population that should be included in the study
Endovascular therapy versus medical treatment for spontaneous isolated dissection of the superior mesenteric artery
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Dissection of mesenteric artery
Provide patient population that should be included in the study
Catheter‐directed therapies for the treatment of high risk (massive) and intermediate risk (submassive) acute pulmonary embolism
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Acute Pulmonary Embolism
Provide patient population that should be included in the study
Action observation for upper limb rehabilitation after stroke
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Stroke 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Upper limb motor deficit 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Patch angioplasty versus primary closure for carotid endarterectomy
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Carotid Endarterectomy 6. Aged 65-79 years
Provide patient population that should be included in the study
Antiplatelet agents for the treatment of deep venous thrombosis
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Aged 65-79 years 10. Adolescent 13-18 years 11. Deep Venous Thrombosis
Provide patient population that should be included in the study
Type of anaesthesia for acute ischaemic stroke endovascular treatment
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Ischemic Stroke 6. Aged 65-79 years
Provide patient population that should be included in the study
Heparin versus 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults
1. Aged 80 and over 80+ years 2. Central Venous Catheter Occlusion 3. Adult 19-44 years 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Local intramuscular transplantation of autologous bone marrow mononuclear cells for critical lower limb ischaemia
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Critical Lower Limb Ischemia 6. Aged 65-79 years
Provide patient population that should be included in the study
Routine or selective carotid artery shunting for carotid endarterectomy (and different methods of monitoring in selective shunting)
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Bilateral Carotid Endarterectomy 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Unilateral Carotid Endarterectomy 7. Aged 65-79 years
Provide patient population that should be included in the study
Corticosteroids for the treatment of Kawasaki disease in children
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Infant 1 to 23 mo 4. Kawasaki's syndrome 5. Birth to 1 mo 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Percutaneous transluminal angioplasty and stenting for vertebral artery stenosis
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Stroke 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Vertebral Artery Stenosis 7. Aged 65-79 years 8. Transient Cerebral Ischemia
Provide patient population that should be included in the study
Outpatient versus inpatient treatment for acute pulmonary embolism
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Adolescent 13-18 years 7. Acute Pulmonary Embolism
Provide patient population that should be included in the study
Endovascular versus conventional open surgical repair for thoracoabdominal aortic aneurysms
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Thoracoabdominal Aortic Aneurysm 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Occupational therapy for cognitive impairment in stroke patients
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Stroke 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Cognitive impairment
Provide patient population that should be included in the study
Angioplasty versus stenting for subclavian artery stenosis
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Subclavian artery stenosis
Provide patient population that should be included in the study
Ultrafiltration for acute heart failure
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Adolescent 13-18 years 7. Acute Heart Failure
Provide patient population that should be included in the study
Oral antiplatelet therapy for acute ischaemic stroke
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Ischemic Stroke 6. Aged 65-79 years
Provide patient population that should be included in the study
Calcium channel blockers versus other classes of drugs for hypertension
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Hypertensive disorder
Provide patient population that should be included in the study
Percutaneous thrombectomy or ultrasound‐accelerated thrombolysis for initial management of acute limb ischaemia
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Acute Limb Ischaemia
Provide patient population that should be included in the study
Propionyl‐L‐carnitine for intermittent claudication
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Intermittent claudication 6. Peripheral Arterial Disease 7. Aged 65-79 years
Provide patient population that should be included in the study
Psychological and pharmacological interventions for depression in patients with coronary artery disease
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Depression 6. Coronary Artery Disease 7. Aged 65-79 years
Provide patient population that should be included in the study
Endovascular versus open surgical repair for complicated chronic Type B aortic dissection
1. Type B Aortic Dissection
Provide patient population that should be included in the study
Injection sclerotherapy for varicose veins
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Varicose Veins 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Environmental enrichment for stroke and other non‐progressive brain injury
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Stroke 4. Middle Aged 45-64 years 5. Acquired Brain Injury 6. Young Adult 19-24 years 7. Aged 65-79 years
Provide patient population that should be included in the study
Renal denervation for resistant hypertension
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Essential Hypertension 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventions for altering blood pressure in people with acute subarachnoid haemorrhage
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Subarachnoid Hemorrhage 6. Aged 65-79 years
Provide patient population that should be included in the study
Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Stroke 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years